Angiotensinogen (AGT) Human Recombinant Protein

Essential component of the renin-angiotensin system (RAS), a potent regulator of blood pressure, body fluid and electrolyte homeostasis. Angiotensin-2: acts directly on vascular smooth muscle as a potent vasoconstrictor, affects cardiac contractility and heart rate through its action on the sympathetic nervous system, and alters renal sodium and water absorption through its ability to stimulate the zona glomerulosa cells of the adrenal cortex to synthesize and secrete aldosterone. Angiotensin-3: stimulates aldosterone release. Angiotensin 1-7: is a ligand for the G-protein coupled receptor MAS1. Has vasodilator and antidiuretic effects. Has an antithrombotic effect that involves MAS1-mediated release of nitric oxide from platelets.

Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence.Kageyama R., Ohkubo H., Nakanishi S.Biochemistry 23:3603-3609(1984) Structure of human angiotensinogen gene.Gaillard I., Clauser E., Corvol P.DNA 8:87-99(1989) Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter.Fukamizu A., Takahashi S., Seo M.S., Tada M., Tanimoto K., Uehara S., Murakami K.J. Biol. Chem. 265:7576-7582(1990) Molecular cloning of human angiotensinogen cDNA and evidence for the presence of its mRNA in rat heart.Kunapuli S.P., Kumar A.Circ. Res. 60:786-790(1987) Tissue specific hormonal regulation of the rat angiotensinogen gene expression.Kunapuli S.P., Benedict C.R., Kumar A.Arch. Biochem. Biophys. 254:642-646(1987) The amino terminal amino acid sequence of human angiotensinogen.Tewksbury D.A., Dart R.A., Travis J.Biochem. Biophys. Res. Commun. 99:1311-1315(1981) Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma.Oxvig C., Haaning J., Kristensen L., Wagner J.M., Rubin I., Stigbrand T., Gleich G.J., Sottrup-Jensen L.J. Biol. Chem. 270:13645-13651(1995) Enzymatic degradation and electrophoresis of human angiotensin I.Arakawa K., Minohara A., Yamada J., Nakamura M.Biochim. Biophys. Acta 168:106-112(1968) Processing of rat and human angiotensinogen precursors by microsomal membranes.Campbell D.J., Bouhnik J., Coezy E., Menard J., Corvol P.Mol. Cell. Endocrinol. 43:31-40(1985) Angiotensin III (DES-Aspartic Acid-1) -Angiotensin II. Evidence and speculation for its role as an important agonist in the renin - angiotensin system.Goodfriend T.L., Peach M.J.Circ. Res. 36:38-48(1975) The renin-angiotensin-aldosterone system a specific target for hypertension management.Weir M.R., Dzau V.J.Am. J. Hypertens. 12:205S-213S(1999) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R.E., Acton S.Circ. Res. 87:E1-E9(2000) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M.A., Nichols A., Tummino P.J. Biol. Chem. 277:14838-14843(2002) Evaluation of angiotensin-converting enzyme (ACE) , its homologue ACE2 and neprilysin in angiotensin peptide metabolism.Rice G.I., Thomas D.A., Grant P.J., Turner A.J., Hooper N.M.Biochem. J. 383:45-51(2004) Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D.J. Proteome Res. 4:2070-2080(2005) Mass-spectrometric identification of a novel angiotensin peptide in human plasma.Jankowski V., Vanholder R., van der Giet M., Tolle M., Karadogan S., Gobom J., Furkert J., Oksche A., Krause E., Tran T.N., Tepel M., Schuchardt M., Schluter H., Wiedon A., Beyermann M., Bader M., Todiras M., Zidek W., Jankowski J.Arterioscler. Thromb. Vasc. Biol. 27:297-302(2007) Renin-angiotensin system revisited.Fyhrquist F., Saijonmaa O.J. Intern. Med. 264:224-236(2008) Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.J. Proteome Res. 8:651-661(2009) Initial characterization of the human central proteome.Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.BMC Syst. Biol. 5:17-17(2011) An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., Ye M., Zou H.J. Proteomics 96:253-262(2014) The octapeptide angiotensin II adopts a well-defined structure in a phospholipid environment.Carpenter K.A., Wilkes B.C., Schiller P.W.Eur. J. Biochem. 251:448-453(1998) Comparison of the solution structures of angiotensin I & II. Implication for structure-function relationship.Spyroulias G.A., Nikolakopoulou P., Tzakos A., Gerothanassis I.P., Magafa V., Manessi-Zoupa E., Cordopatis P.Eur. J. Biochem. 270:2163-2173(2003) A redox switch in angiotensinogen modulates angiotensin release.Zhou A., Carrell R.W., Murphy M.P., Wei Z., Yan Y., Stanley P.L., Stein P.E., Broughton Pipkin F., Read R.J.Nature 468:108-111(2010) Molecular basis of human hypertension role of angiotensinogen.Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., Lalouel J.-M., Corvol P.Cell 71:169-180(1992) A molecular variant of angiotensinogen associated with preeclampsia.Ward K., Hata A., Jeunemaitre X., Helin C., Nelson L., Namikawa C., Farrington P.F., Ogasawara M., Suzumori K., Tomoda S., Berrebi S., Sasaki M., Corvol P., Lifton R.P., Lalouel J.-M.Nat. Genet. 4:59-61(1993) Detection and characterization of new mutations in the human angiotensinogen gene (AGT) .Hixson J.E., Powers P.K.Hum. Genet. 96:110-112(1995) A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system.Inoue I., Rohrwasser A., Helin C., Jeunemaitre X., Crain P., Bohlender J., Lifton R.P., Corvol P., Ward K., Lalouel J.-M.J. Biol. Chem. 270:11430-11436(1995) The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein.Gimenez-Roqueplo A.P., Leconte I., Cohen P., Simon D., Guyene T.T., Celerier J., Pau B., Corvol P., Clauser E., Jeunemaitre X.J. Biol. Chem. 271:9838-9844(1996) Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis.Gribouval O., Gonzales M., Neuhaus T., Aziza J., Bieth E., Laurent N., Bouton J.M., Feuillet F., Makni S., Ben Amar H., Laube G., Delezoide A.-L., Bouvier R., Dijoud F., Ollagnon-Roman E., Roume J., Joubert M., Antignac C., Gubler M.-C.Nat. Genet. 37:964-968(2005)

Small volumes of AGT recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS954800 is a recombinant protein targeting AGT. Also known as Recombinant Human Angiotensinogen. Host: E Coli or Yeast or Baculovirus or Mammalian Cell.